226 related articles for article (PubMed ID: 37719125)
1. The value of lymphocyte to monocyte ratio in the prognosis of head and neck squamous cell carcinoma: a meta-analysis.
Wei D; Liu J; Ma J
PeerJ; 2023; 11():e16014. PubMed ID: 37719125
[TBL] [Abstract][Full Text] [Related]
2. The lymphocyte-to-monocyte ratio as a prognostic indicator in head and neck cancer: a systematic review and meta-analysis.
Tham T; Olson C; Khaymovich J; Herman SW; Costantino PD
Eur Arch Otorhinolaryngol; 2018 Jul; 275(7):1663-1670. PubMed ID: 29651542
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis.
Nishijima TF; Muss HB; Shachar SS; Tamura K; Takamatsu Y
Cancer Treat Rev; 2015 Dec; 41(10):971-8. PubMed ID: 26481060
[TBL] [Abstract][Full Text] [Related]
4. Association of pre-treatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiation.
Yu B; Ma SJ; Khan M; Gill J; Iovoli A; Fekrmandi F; Farrugia MK; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Seshadri M; Ray AD; Repasky EA; Singh AK
BMC Cancer; 2023 Jun; 23(1):572. PubMed ID: 37344761
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: a meta-analysis.
Lee SF; Ng TY; Spika D
BMC Cancer; 2019 Apr; 19(1):338. PubMed ID: 30971203
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of pretreatment lymphocyte-to-monocyte ratio in patients with glioma: a meta-analysis.
Wang Y; Xu C; Zhang Z
BMC Med; 2023 Dec; 21(1):486. PubMed ID: 38053096
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of lymphocyte to monocyte ratio in pancreatic cancer: a systematic review and meta-analysis including 3338 patients.
Lin S; Fang Y; Mo Z; Lin Y; Ji C; Jian Z
World J Surg Oncol; 2020 Jul; 18(1):186. PubMed ID: 32711514
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of lymphocyte-to-monocyte ratio in gastric cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
Mei P; Feng W; Zhan Y; Guo X
Front Immunol; 2023; 14():1321584. PubMed ID: 38090560
[TBL] [Abstract][Full Text] [Related]
9. Systemic immune response in squamous cell carcinoma of the head and neck: a comparative concordance index analysis.
Tham T; Wotman M; Chung C; Ahn S; Dupuis H; Gliagias V; Movsesova T; Kraus D; Costantino P
Eur Arch Otorhinolaryngol; 2019 Oct; 276(10):2913-2922. PubMed ID: 31312922
[TBL] [Abstract][Full Text] [Related]
10. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
[TBL] [Abstract][Full Text] [Related]
11. Correlation between preoperative peripheral blood NLR, PLR, LMR and prognosis of patients with head and neck squamous cell carcinoma.
Zhou J; Wei S; Guo X; Huang Y; Zhang Y; Hong Y; Chen X; Lu M; Zheng F; Zheng C
BMC Cancer; 2023 Dec; 23(1):1247. PubMed ID: 38110870
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Pretreatment Lymphocyte-to-Monocyte Ratio in Lung Cancer: A Systematic Review and Meta-Analysis.
Jin J; Yang L; Liu D; Li WM
Technol Cancer Res Treat; 2021; 20():1533033820983085. PubMed ID: 33576324
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Lymphocyte-to-Monocyte Ratio (LMR) in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis.
Xiang Q; Liu Y; Xiao J; Ou L; Du J
Am J Mens Health; 2024; 18(2):15579883241234747. PubMed ID: 38514969
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte-to-monocyte ratio in esophageal squamous cell carcinoma prognosis.
Hu G; Liu G; Ma JY; Hu RJ
Clin Chim Acta; 2018 Nov; 486():44-48. PubMed ID: 30028962
[TBL] [Abstract][Full Text] [Related]
15. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
[TBL] [Abstract][Full Text] [Related]
16. High pretreatment neutrophil-to-lymphocyte ratio as a predictor of poor survival prognosis in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Yang L; Huang Y; Zhou L; Dai Y; Hu G
Head Neck; 2019 May; 41(5):1525-1535. PubMed ID: 30597654
[TBL] [Abstract][Full Text] [Related]
17. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of lymphocyte-to-monocyte ratio among Asian lung cancer patients: a systematic review and meta-analysis.
Li W; Ma G; Wu Q; Deng Y; Liu Y; Wang J
Oncotarget; 2017 Dec; 8(66):110606-110613. PubMed ID: 29299172
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of lymphocyte-to-monocyte ratio in ovarian cancer: a meta-analysis.
Gong J; Jiang H; Shu C; Hu MQ; Huang Y; Liu Q; Li RF
J Ovarian Res; 2019 May; 12(1):51. PubMed ID: 31151469
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of pretreatment lymphocyte-to-monocyte ratio in advanced epithelial cancers: a meta-analysis.
Mao Y; Chen D; Duan S; Zhao Y; Wu C; Zhu F; Chen C; Chen Y
Cancer Cell Int; 2018; 18():201. PubMed ID: 30534002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
